Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 24 Nov 2021 for Adamas Pharmaceuticals Inc.
Insider track record
Disclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Spyridon Papapetropoulos: trading record in brief
Spyridon Papapetropoulos, listed as board member, appears in our data through filings on Adamas Pharmaceuticals Inc shares, published by SEC (Form 4). In total, 4 filings cover trades dated from 22 November 2020 to 24 November 2021.
Every open-market trade on record is a purchase: 1 purchase worth €25k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 2 share grants. So far in 2021, the count stands at 1 purchase and no sales.
The newest entry dates from 24 November 2021: a transaction, in Adamas Pharmaceuticals Inc. The latest purchase dates back some time: it was published 2,048 days ago, on 15 March 2021. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Spyridon Papapetropoulos
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
20,975 sharesCommon StockSEC:0001328143-21-000089:0
5,000 shares0Common StockSEC:0001328143-21-000060:0
2 of 2 declarations
